Robin Lemmens is a Professor at the Faculty of Medicine, KU Leuven, and leads the Laboratory of Neurobiology (VIB-KU Leuven). He serves as head of Academic Consultants Training in Specialist Medicine and Program Director of the POC Medical Specialist in Training. His affiliations include the LBI - KU Leuven Brain Institute and membership in multiple institutional committees including the Metaforum Steering Committee and Faculty Council of Medicine. Dr. Lemmens' research focuses on stroke neurology with particular expertise in neuroimaging, cerebrovascular diseases, and endovascular therapy. His work spans ischemic stroke management, anticoagulation therapy, intracerebral hemorrhage, and advanced imaging techniques for stroke diagnosis and treatment planning. Current research explores AI applications in stroke imaging, optimal timing of anticoagulation after stroke, and endovascular therapy in extended time windows. Analysis of recent publications reveals a strong emphasis on translational stroke research with significant contributions to clinical trial methodology. Key themes include validation of imaging biomarkers, optimization of thrombolytic and anticoagulant therapies, and development of AI tools for stroke lesion segmentation. His work frequently appears in high-impact journals including Stroke , Neurology , and The Lancet . Dr. Lemmens supervises research projects and students, with recent supervision including Oosterbos, C. on peroneal nerve entrapment research. His grant portfolio includes multiple active projects totaling millions in funding, with recent grants focusing on secondary stroke prevention, comprehensive stroke management systems, and AI for stroke outcome prediction. He leads the Laboratory of Neurobiology at VIB-KU Leuven, which collaborates extensively with international stroke research networks. Current research directions include developing patient-centered stroke care pathways, advanced imaging techniques for early ischemic changes, and personalized stroke diagnostics and treatment protocols.